dc.contributor.author | Nguyen, Anvy | |
dc.contributor.author | Aydogan, Fatih | |
dc.contributor.author | Wong, Stephanie M. | |
dc.contributor.author | Barry, William T. | |
dc.contributor.author | Golshan, Mehra | |
dc.contributor.author | Sagara, Yasuaki | |
dc.contributor.author | Freedman, Rachel A. | |
dc.date.accessioned | 2021-03-05T07:09:44Z | |
dc.date.available | 2021-03-05T07:09:44Z | |
dc.date.issued | 2017 | |
dc.identifier.citation | Sagara Y., Freedman R. A. , Wong S. M. , Aydogan F., Nguyen A., Barry W. T. , Golshan M., "Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013", BREAST CANCER RESEARCH AND TREATMENT, cilt.166, ss.583-592, 2017 | |
dc.identifier.issn | 0167-6806 | |
dc.identifier.other | av_925567f7-7380-4060-a522-f9e3d07d77bd | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/98704 | |
dc.identifier.uri | https://doi.org/10.1007/s10549-017-4436-9 | |
dc.description.abstract | Breast-conserving surgery (BCS) followed by radiotherapy (RT) with or without endocrine therapy (ET) is a standard treatment option for ductal carcinoma in situ (DCIS). We sought to investigate national patterns in the use of adjuvant therapy after BCS for hormone receptor (HR)-positive DCIS over time. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013 | |
dc.type | Makale | |
dc.relation.journal | BREAST CANCER RESEARCH AND TREATMENT | |
dc.contributor.department | Harvard University , , | |
dc.identifier.volume | 166 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 583 | |
dc.identifier.endpage | 592 | |
dc.contributor.firstauthorID | 247426 | |